Biotech news
Biotech
Merck will divest its biosimilars business to Fresenius Kabi in order to focus on innovative drugs. 28 April 2017
Americas
The US Supreme Court heard oral arguments from Amgen and Sandoz yesterday in the ongoing battle over a biosimilar version of Amgen’s Neupogen. 27 April 2017
Americas
The US Court of Appeals for the Federal Circuit has partly affirmed, partly reversed and partly vacated a dispute between Duke University, based in North Carolina, and biotech company BioMarin Pharmaceutical. 27 April 2017
Americas
Merck and PDL Biopharma have settled a dispute over Merck’s cancer drug Keytruda (pembrolizumab), which allegedly infringed a patent belonging to PDL. 27 April 2017
Americas
LSIPR and law firm HGF held a webinar yesterday focusing on CRISPR and how to navigate the IP landscape. 26 April 2017
Americas
The US Supreme Court will hear oral arguments from Sandoz and Amgen tomorrow, when the battle over a biosimilar of Amgen’s Neupogen will resume. 25 April 2017
Americas
A disagreement over how pharma patents in Brazil are examined seems to have come to an end, as Breno Souza, Luisa Rezende and Silvia Costa of Clarke Modet & Co Brazil report. 25 April 2017
Americas
Harvard Stem Cells Institute, a network of stem cell scientists, has entered into a collaboration agreement with stem cells manufacturer Cellular Dynamics International. 20 April 2017
Americas
US-based law firm Honigman Miller Schwartz and Cohn has hired Simeon Papacostas as a partner in the firm’s IP department. 20 April 2017
Americas
The University of California, Berkeley and the University of Vienna have appealed against the Patent Trial and Appeal Board's decision in the dispute over CRISPR technology. 18 April 2017